Development and use of iron oxide nanoparticles ( Part 1 ) : Synthesis of iron oxide nanoparticles for MRI

Contrast agents, such as iron oxide, enhance MR images by altering the relaxation times of tissues in which the agent is present. They can also be used to label targeted molecular imaging probes. Unfortunately, no molecular imaging probe is currently available on the clinical MRI market. A promising platform for MRI contrast agent development is nanotechnology, where superparamagnetic iron oxide nanoparticles (SPIONS) are tailored for MR contrast enhancement, and/or for molecular imaging. SPIONs can be produced using a range of methods and the choice of method will be influenced by the characteristics most important for a particular application. In addition, the ability to attach molecular markers to SPIONS heralds their application in molecular imaging. There are many reviews on SPION synthesis for MRI; however, these tend to be targeted to a chemistry audience. The development of MRI contrast agents attracts experienced researchers from many fields including some researchers with little knowledge of medical imaging or MRI. This situation presents medical radiation practitioners with opportunities for involvement, collaboration or leadership in research depending on their level of commitment and their ability to learn. Medical radiation practitioners already possess a large portion of the understanding, knowledge and skills necessary for involvement in MRI development and molecular imaging. Their expertise in imaging technology, patient care and radiation safety provides them with skills that are directly applicable to research on the development and application of SPIONs and MRI. In this paper we argue that MRI SPIONs, currently limited to major research centres, will have widespread clinical use in the future. We believe that knowledge about this growing area of research provides an opportunity for medical radiation practitioners to enhance their specialised expertise to ensure best practice in a truly multi-disciplinary environment. This review outlines how and why SPIONs can be synthesised and examines their characteristics and limitations in the context of MR imaging.

[1]  Jeff W M Bulte,et al.  Iron oxide MR contrast agents for molecular and cellular imaging , 2004, NMR in biomedicine.

[2]  M. Saunders,et al.  Magnetite Nanoparticle Dispersions Stabilized with Triblock Copolymers , 2003 .

[3]  E. Paterson.  The Iron Oxides. Structure, Properties, Reactions, Occurrences and Uses , 1999 .

[4]  M. Muhammed,et al.  Synthesis and characterization of surfactant-coated superparamagnetic monodispersed iron oxide nanoparticles , 2001 .

[5]  Xiaoping P. Hu,et al.  Functionalization and peptide-based delivery of magnetic nanoparticles as an intracellular MRI contrast agent , 2004, JBIC Journal of Biological Inorganic Chemistry.

[6]  J. Bulte,et al.  Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran‐magnetite particles , 1993, Magnetic resonance in medicine.

[7]  Jeff W. M. Bulte,et al.  Synthesis and Characterization of Soluble Iron Oxide−Dendrimer Composites , 2001 .

[8]  C. Serna,et al.  The formation of a–Fe_2O_3 monodispersed particles in solution , 1992 .

[9]  Taeghwan Hyeon,et al.  Synthesis of highly crystalline and monodisperse maghemite nanocrystallites without a size-selection process. , 2001, Journal of the American Chemical Society.

[10]  J. Bulte,et al.  Short‐ vs. long‐circulating magnetoliposomes as bone marrow‐seeking MR contrast agents , 1999, Journal of magnetic resonance imaging : JMRI.

[11]  Trevor Douglas,et al.  In vivo magnetic resonance tracking of olfactory ensheathing glia grafted into the rat spinal cord , 2004, Experimental Neurology.

[12]  Hiroyuki Honda,et al.  Medical application of functionalized magnetic nanoparticles. , 2005, Journal of bioscience and bioengineering.

[13]  R. Molday,et al.  Immunospecific ferromagnetic iron-dextran reagents for the labeling and magnetic separation of cells. , 1982, Journal of immunological methods.

[14]  A. Rehemtulla,et al.  Molecular Imaging , 2009, Methods in Molecular Biology.

[15]  Tronc,et al.  Size Tailoring of Magnetite Particles Formed by Aqueous Precipitation: An Example of Thermodynamic Stability of Nanometric Oxide Particles. , 1998, Journal of colloid and interface science.

[16]  Trevor Douglas,et al.  MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain , 2003, Magnetic resonance in medicine.

[17]  Philippe Robert,et al.  Recent advances in iron oxide nanocrystal technology for medical imaging. , 2006, Advanced drug delivery reviews.

[18]  R. Thompson,et al.  Analysis of the formation of monodisperse populations by homogeneous nucleation , 1991 .

[19]  Jinwoo Cheon,et al.  Surface modulation of magnetic nanocrystals in the development of highly efficient magnetic resonance probes for intracellular labeling. , 2005, Journal of the American Chemical Society.

[20]  K. Kandori,et al.  Preparation and characterization of monodisperse magnetite sols in microemulsion , 1983 .

[21]  A. Bée,et al.  Thiolation of Maghemite Nanoparticles by Dimercaptosuccinic Acid , 1997, Journal of colloid and interface science.

[22]  A. Hütten,et al.  Characterization of nano-magnetic structures , 1997 .

[23]  Yu Zhang,et al.  An improved way to prepare superparamagnetic magnetite-silica core-shell nanoparticles for possible biological application , 2005 .

[24]  J. Bulte,et al.  Noninvasive monitoring of stem cell transfer for muscle disorders , 2004, Magnetic Resonance in Medicine.

[25]  V. Lamer,et al.  Theory, Production and Mechanism of Formation of Monodispersed Hydrosols , 1950 .

[26]  V. Vogel,et al.  Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  R Weissleder,et al.  Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. , 2000, Radiology.

[28]  Jinwoo Cheon,et al.  Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging , 2007, Nature Medicine.

[29]  Jin-Sil Choi,et al.  In vivo magnetic resonance detection of cancer by using multifunctional magnetic nanocrystals. , 2005, Journal of the American Chemical Society.

[30]  Weihong Tan,et al.  Synthesis and Characterization of Silica-Coated Iron Oxide Nanoparticles in Microemulsion: The Effect of Nonionic Surfactants , 2001 .

[31]  W. Kaiser,et al.  MR imaging of Her-2/neu protein using magnetic nanoparticles , 2007, Nanotechnology.

[32]  Sophie Neveu,et al.  Synthesis of very fine maghemite particles , 1995 .

[33]  R. Massart,et al.  Preparation of aqueous magnetic liquids in alkaline and acidic media , 1981 .

[34]  Yajun Wang,et al.  Templated synthesis of single-component polymer capsules and their application in drug delivery. , 2008, Nano letters.

[35]  C. Serna,et al.  Synthesis, Properties and Biomedical Applications of Magnetic Nanoparticles. , 2008 .

[36]  A. Bée,et al.  Adsorption of gluconic and citric acids on maghemite particles in aqueous medium , 1996 .

[37]  S. Nie,et al.  In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.

[38]  E. Groman,et al.  Synthesis of ultrasmall superparamagnetic iron oxides using reduced polysaccharides. , 2004, Bioconjugate chemistry.

[39]  Pedro Tartaj,et al.  Microemulsion-Assisted Synthesis of Tunable Superparamagnetic Composites , 2002 .

[40]  Shieh-Yueh Yang,et al.  Preparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatible , 2004 .

[41]  Hao Zeng,et al.  Monodisperse MFe2O4 (M = Fe, Co, Mn) nanoparticles. , 2004, Journal of the American Chemical Society.

[42]  C. Serna,et al.  Uniform colloidal particles in solution: Formation mechanisms , 1995 .

[43]  J. Rivas,et al.  Preparation of magnetic fluids with particles obtained in microemulsions , 1997 .

[44]  E. Matijević,et al.  Preparation and properties of uniform coated colloidal particles. VII. Silica on hematite , 1992 .

[45]  E. Jeong,et al.  Noninvasive Visualization of In Vivo Drug Delivery of Paramagnetic Polymer Conjugates with MRI , 2006 .

[46]  E. Tronc,et al.  Influence of Fe(II) on the Formation of the Spinel Iron Oxide in Alkaline Medium , 1992 .

[47]  U. Schubert,et al.  Metallo‐supramolecular micelles: Studies by analytical ultracentrifugation and electron microscopy , 2003 .

[48]  R. Regmi.  Properties and biomedical applications of magnetic nanoparticles , 2011 .

[49]  H. Möhwald,et al.  Maghemite nanoparticles protectively coated with poly(ethylene imine) and poly(ethylene oxide)-block-poly(glutamic acid). , 2006, Langmuir : the ACS journal of surfaces and colloids.

[50]  Xiaogang Peng,et al.  Kinetics of II-VI and III-V Colloidal Semiconductor Nanocrystal Growth: “Focusing” of Size Distributions , 1998 .

[51]  Physics of Amphiphiles : Micelles , Vesicles and Microemulsion , 1993 .

[52]  Ajay Kumar Gupta,et al.  Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. , 2005, Biomaterials.

[53]  Jinwoo Cheon,et al.  Nanoscale size effect of magnetic nanocrystals and their utilization for cancer diagnosis via magnetic resonance imaging. , 2005, Journal of the American Chemical Society.

[54]  M. El-Sayed,et al.  Chemistry and properties of nanocrystals of different shapes. , 2005, Chemical reviews.

[55]  Taeghwan Hyeon,et al.  Ultra-large-scale syntheses of monodisperse nanocrystals , 2004, Nature materials.

[56]  Hao Zeng,et al.  Size-controlled synthesis of magnetite nanoparticles. , 2002, Journal of the American Chemical Society.

[57]  A. Lu,et al.  Magnetic nanoparticles: synthesis, protection, functionalization, and application. , 2007, Angewandte Chemie.

[58]  B. Chu,et al.  Preparation and Properties of Magnetite and Polymer Magnetite Nanoparticles , 1999 .

[59]  Woo-Sik Kim,et al.  Properties of iron oxide particles prepared in the presence of dextran , 2002 .

[60]  J. Astier,et al.  Crystallization mechanisms in solution , 1988 .

[61]  N. Nassar,et al.  Preparation of iron oxide nanoparticles from FeCl3 solid powder using microemulsions , 2006 .

[62]  Babeş,et al.  Synthesis of Iron Oxide Nanoparticles Used as MRI Contrast Agents: A Parametric Study. , 1999, Journal of colloid and interface science.

[63]  R. Lawaczeck,et al.  Superparamagnetic iron oxide particles: contrast media for magnetic resonance imaging , 2004 .

[64]  H. Acar,et al.  Superparamagnetic nanoparticles stabilized by polymerized PEGylated coatings , 2005 .

[65]  B. Berne,et al.  Dynamic Light Scattering: With Applications to Chemistry, Biology, and Physics , 1976 .

[66]  S. Nie,et al.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection. , 1998, Science.

[67]  D. Little,et al.  Imaging GABAc Receptors with Ligand-Conjugated Quantum Dots , 2008, Journal of biomedicine & biotechnology.

[68]  J. Bulte,et al.  Magnetoliposomes as contrast agents. , 2003, Methods in enzymology.

[69]  C. Robic,et al.  Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. , 2008, Chemical reviews.

[70]  R. Pecora.  Dynamic Light Scattering , 1985 .

[71]  Tymish Y. Ohulchanskyy,et al.  Aqueous ferrofluid of magnetite nanoparticles: Fluorescence labeling and magnetophoretic control. , 2005, The journal of physical chemistry. B.

[72]  C. Labrugère,et al.  Sonochemical approach to the synthesis of Fe(3)O(4)@SiO(2) core-shell nanoparticles with tunable properties. , 2008, ACS nano.

[73]  Klaas Nicolay,et al.  Lipid‐based nanoparticles for contrast‐enhanced MRI and molecular imaging , 2006, NMR in biomedicine.

[74]  Youjia Cao,et al.  Biocompatible superparamagnetic iron oxide nanoparticle dispersions stabilized with poly(ethylene glycol)-oligo(aspartic acid) hybrids. , 2007, Journal of biomedical materials research. Part A.

[75]  U. Schwertmann,et al.  The Iron Oxides: Structure, Properties, Reactions, Occurrences and Uses , 2003 .

[76]  Taeghwan Hyeon,et al.  Large‐Scale Synthesis of Uniform and Crystalline Magnetite Nanoparticles Using Reverse Micelles as Nanoreactors under Reflux Conditions , 2005 .

[77]  D. Balding,et al.  HLA Sequence Polymorphism and the Origin of Humans , 2006 .

[78]  Joohee Jung,et al.  Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[79]  P. Petroff,et al.  Fabrication of hcp-Co Nanocrystals via Rapid Pyrolysis in Inverse PS-b-PVP Micelles and Thermal Annealing , 2003 .

[80]  A. Curtis,et al.  Cell response to dextran-derivatised iron oxide nanoparticles post internalisation. , 2004, Biomaterials.

[81]  Wei Liu,et al.  Synthesis of superparamagnetic nanotubes as MRI contrast agents and for cell labeling. , 2008, Nanomedicine.

[82]  M. de Cuyper,et al.  Magnetoliposomes , 1988, European Biophysics Journal.

[83]  J. Bulte,et al.  Preparation, relaxometry, and biokinetics of PEGylated magnetoliposomes as MR contrast agent , 1999 .

[84]  E. Matijević,et al.  Preparation and properties of uniform coated colloidal particles , 1990 .

[85]  B. Lorber,et al.  The crystallization of biological macromolecules from precipitates : evidence for Ostwald ripening , 1996 .

[86]  Oxygenation of ferrous ions in reversed micelle and reversed microemulsion , 1982 .